echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Neuro Oncol: Hormone therapy will worsen the overall survival and progression-free survival of patients with brain metastases!

    Neuro Oncol: Hormone therapy will worsen the overall survival and progression-free survival of patients with brain metastases!

    • Last Update: 2021-03-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Immune checkpoint inhibitors (ICI) have become a breakthrough treatment for certain cancer patients including brain metastases (BM).


    immunity

    This study aims to conduct a systematic literature review and meta-analysis of the relationship between steroid therapy and overall survival (OS) in BM patients treated with ICI.


    This study aims to conduct a systematic literature review and meta-analysis of the relationship between steroid therapy and overall survival (OS) in BM patients treated with ICI.


    1145 studies were screened and 15 observational studies were included.


    Forest plot of overall survival (OS) hazard ratio (HR) for patients with brain metastases in the steroid and non-steroid groups

    Forest plot of overall survival (OS) hazard ratio (HR) for patients with brain metastases in the steroid and non-steroid groups

    The median OS of patients in the steroid group was 2.


    The median OS of patients in the steroid group was 2.


    In BM patients receiving ICI treatment, hormone therapy was associated with a significant deterioration in OS and PFS.


    Original source:

    Jessurun Charissa AC, Hulsbergen Alexander FC, de Wit Anouk E et al.


    org/10.
    1093/neuonc/noab046">The combined use of steroids and immune checkpoint inhibitors in brain metastasis patients: a systematic review and meta-analysis in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.